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Summary
Cyclic adenosine 5’- monophosphate (cAMP) is an ancient signaling molecule 
and one of its primary eukaryotic targets is cAMP-dependent protein kinase A
(PKA). PKA when inactive exists as a tetrameric complex of a dimeric regulatory 
subunit (PKA-R) and two monomeric catalytic subunits (PKA-C). The activity  of 
PKA is regulated by binding of cAMP to the regulatory subunits in the inactive 
complex and releasing the PKA-C subunits. The signal for PKA-C dissociation 
and activation  is hypothesized to be propagated through two charge relays, 
namely the Arg209- and Glu200- mediated signal relays, the molecular details of 
which are as yet unknown. This activation mechanism plays out through a 
ternary intermediate state consisting of the PKA-holoenzyme bound to cAMP, 
which occurs transiently  before dissociation.The study of this transient complex 
can provide valuable insights into the activation mechanism of PKA and  also 
help in the design of therapeutic moleclues. This intermediate state was studied 
using Rp-cAMPS, a cAMP analog which is capable of locking the ternary 
complex. Rp-cAMPS blocks the Arg209 mediated signal relay required for 
dissociation while the Glu200 mediated relay remains undisturbed. The ternary 
complex provided insights into the possible conformation of the intermediate 
state in PKA- activation as well as the role of the Glu200-mediated interaction. 
Amide Hydrogen/Deuterium exchange followed by mass spectrometry was 
employed to compare conformational differences of the holoenzyme in the free 
and  the Rp-cAMPS bound form.
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1.Introduction
1.1 cAMP Signaling Pathway
 Cyclic adenosine 5’- monophosphate (cAMP) acts as an important second 
messenger by mediating a plethora of cellular processes through the cAMP-
mediated signaling pathway (Fig 1-1) (1,2). Extracellular ligands bind to a large 
family of integral membrane proteins called the G-protein-coupled receptors 
(GPCRs). Specific ligands bind to and activate each GPCR. This activation of the 
receptors is followed by a conformational change in the attached heterotrimeric 
G-protein complex which leads to the release of the Gs alpha subunit upon 
exchanging GDP for GTP. This activated Gs alpha protein then binds to a 
membrane bound enzyme called adenylyl cyclase and activates it. The activated 
adenylyl cyclase then catalyses the conversion of adenosine triphosphate (ATP) 
to cAMP (2). 
 cAMP translates the extracellular stimuli signals to downstream responses 
upon binding to specific receptors. The primary  downstream receptor for cAMP 
in bacteria is the catabolite gene activator protein (CAP) which regulates gene 
expression (3). While in eukaryotic cells, cAMP binds to the regulatory subunit of 
cAMP-dependent protein kinase (PKA) (4,5) via a conserved cAMP binding 
motif. cAMP also binds the cyclic nucleotide-gated channels and the guanine 
nucleotide exchange proteins (EPAC) through the same motif (6,7,8). The levels 
of cAMP are regulated by phosphodiesterases (PDE) which hydrolyze cAMP into 
5’-AMP.
Figure 1-1. cAMP Signaling pathway (1,2)
1.2 cAMP-dependent Protein Kinase 
Most known biological effects of cAMP in mammalian cells are mediated 
through the two ubiquitous isoforms of the regulatory (R) subunit of PKA, types I 
and II (9). The regulatory subunits of these isoforms are further classified into α- 
and β- forms each. The four distinct R-subunits (RIα, RIβ, RIIα and RII β) share 
a similar domain organization (Fig1-2) but are expressed by different genes (10). 
The amino terminal end consists of a docking/dimerization domain , which apart 
from allowing the R-subunits to exist as stable dimers also mediate docking to A 
kinase anchoring proteins(AKAPs). AKAPs act as scaffolds as well as help 
localize the holoenzyme to various cellular sites. A variable linker region follows 
which consists of a pseudosubstrate/inhibitor motif that interacts with the active 





























domains (CBD-A and CBD-B), at the carboxy terminal each have cAMP binding 
domains with distinct roles. 






Figure 1-2. Domain organization of the PKA Regulatory subunit
 The CBD-B acts as a doorkeeper by binding to a cAMP molecule and then 
allowing cAMP to access the CBD-A (11). The CBD-A has also been found to be 
part of the direct interaction site with PKA-C  (12-14). The CBD-A has been 
shown to have a faster off-rate for cAMP compared to CBD-A (15). In the 
absence of cAMP, PKA exists as an inactive, tetrameric complex consisting of 
one PKA-R homo-dimer  and two PKA-C monomeric subunits. The primary site 
of interaction between PKA-R and PKA-C is the Pseudosubstrate site which 
docks at the active site cleft of the kinase (Fig.1-5). While a peripheral site of 
intersubunit interactions distinct from the pseudosubstrate region, lies within the 
CBD-A.
 The binding of cAMP to the holoenzyme is highly cooperative(16,17) 
where binding  of the first molecule to the CBD-B domain leads to conformational 
changes in the A-domain allowing the second molecule of cAMP to access and 
bind the CBD-A, leading to dissociation of the holoenzyme complex. The 
inactivation of the enzyme follows the same mechanism with the C subunit 
binding the cAMP-bound R subunit and releasing one cAMP from the A domain 
first followed by release of the second cAMP from the B domain(18). 
1.3 Physiological importance of RIα 
 The key compensatory  role of RIα was discovered by gene knockout 
studies of R subunit isoforms in mice. In each case RIα was found to show 
compensatory regulation of PKA activity in tissues where the other R subunits 
are normally expressed. This unique regulatory role of  RIα was further 
concretized by a knockout model of RIα in mice, which turned out to be 
embryonically lethal due to failed cardiac morphogenesis (19). This defect could 
however be rescued by a double knockout model of RIα and PKA-C, suggesting 
unregulated PKA-C  activity was deleterious to the normal functioning of 
eukaryotic cells (19).
1.4 The four state model 
 There are two recognized stable conformations of the R subunit; the 
cAMP saturated, dissociated state and the holoenzyme state. However, two 
transient intermediate states must also be populated in traversing the shifts 
between the cAMP-bound and holoenzyme states (Fig 1-3). During activation, 
there must be a ternary  complex of cAMP, PKA-R and PKA-C  existing as a 
transient intermediate state prior to the dissociation of the complex. While, upon 
dissociation, the cAMP bound R subunit must pass through a cAMP-free and 
unbound to PKA-C  state, before the reformation of the holoenzyme (20). The 
ternary intermediate state is relatively unstable compared to the R-C  holoenzyme 
with a KD of 0.2μM (20,21).
RcAMP+ CMg2ATP
[R] + CMg2ATP
2 x 107 M-1s-1
     R:CMg2ATP
+cAMP +cAMP
4 x 10-3 s-1
2 x 107 M-1s-1
2.6 s-1
0.2nM 0.2µM
        [RcAMP:CMg2ATP]
Anand et al (2007)
Biochemistry
Figure 1-3. A proposed four state model for PKA activation based on the Kinetics of 
intersubunit interactions in the presence and absence of cAMP (20)
1.5 Deletion mutagenesis of RIα 
 Deletion mutants combined with yeast-two hybrid screens were used to 
study the distinct regions in CBD-A involved in mediating high-affinity  interactions 
with PKA-C as well as for binding cAMP. The screens and further analysis 
identified RIα(94-169) as the minimum fragment required to inhibit PKA-C in a 
low micromolar range (22). While some residues in the C-helix(236-260) were 
identified as being important for high affinity binding to PKA-C as well as binding 
to cAMP. The estimated binding affinities of RIα(94-260) and RIα(94-244) were 
both found to be only marginally higher than the KD for full length RIα-C 
interactions (23). RIα(94-244) was hence highlighted as an ideal minimal model 
for binding and interaction studies of the RIα subunit with both cAMP and PKA-C 
(Fig.1-4). 







Figure 1-4.  Domain Organization of RIα shows the boundaries of RIα(91-244). This is 
the minimal module that binds both cAMP and PKA-C with high affinity.
1.6 Kinetics of R subunit interactions with cAMP and C
 The PKA-RC holoenzyme is a high affinity complex with KD values of 
0.4nM and 0.2nM for the wild type RIα and the RIα∆1-91 respectively (22). 
Although wild type PKA RIα in the absence of cAMP binds C-subunit with a 
faster association rate (1.0x 105M-1 s-1) than RIα(91-244)(2.3x 107 M-1s-1) (20), 
the overall binding constants are very  similar. The kinetics of interactions 
between the PKA-R and -C  subunits have been studied in the presence of 
cAMP using stopped-flow fluorimetry  with the deletion construct, RIα(91-244). 
The rates of dissociation of RIα from the C  subunit were 700 fold faster (KD = 
130nM) upon addition of cAMP while the association kinetics remained 
unchanged (20). The presence of substrates could also lead to dissociation of 
the complex but phosphorylated substrates release PKA-C faster, facilitating re-
association of the holoenzyme complex (20).
1.7 Structural Insights into PKA RIα
 As mentioned earlier, the RIα(91-244) double truncated mutant lacks the 
docking/dimerization domain as well as CBD-B and has been extensively studied 
by X-ray crystallography. Detailed analysis reveals that CBD-A in particular and 
both CBDs in general, consist of three α-helices and eight β-strands (24). The 
helical regions make up  the interface for PKA-C interactions while the β sheeted 
regions form the cAMP binding pocket (Fig.1-5).
              
Figure 1-5. The RIα(91-244):C complex was drawn using Pymol with the pdb file 
(accession number- 1u7e) (27) where the sand colored region is PKA-C and the gray 
colored region is PKA RIα(91-244).
1.71 cAMP binding pocket
 The β-strands are arranged in two anti-parallel β  sheets forming a β barrel 
subdomain. Each β-sheet consists of four strands connected in a jelly-roll 
topology (24). A pocket called the phosphate binding cassette (PBC), serves as 
the cAMP binding site and is highly conserved amongst the PKA-R family and 
cAMP-binding proteins in general (Fig.1-6) (25). cAMP binds both domains of 




stacking interactions with a conserved aromatic amino acid at the C-terminal end 
of the C helix (Trp 260) (24). 
 The phosphate and the ribose ring form a network of hydrogen bonds as 
well as mediate electrostatic interactions with residues between β-strands 6 and 
7. The 2’-OH of the ribose ring interacts with Glu200 electrostatically. Within the 
PBC, the equatorial exocyclic oxygen of the cAMP phosphate is anchored to 
Arg209 and Ala210 (Fig. 1-6).
Figure 1-6. The Phosphate Binding Cassette(PBC) highlighting the Sites of Interaction 
with cAMP
 Arg209 plays a very important structural role of a switch which connects 
binding of cAMP to the consequent release of PKA-C. It contacts the backbone 
carbonyl of Asn171 and the carboxylate of Asp170 to transmit the signal of 
cAMP binding (24). A signature sequence has been identified to be conserved 
within the PKA-R family. This sequence allows discrimination among PKA-R, 
cGMP-dependent protein kinase (PKG) and other cAMP binding regulators, as 









1.72  PKA-C binding region on RIα
 The PKA-C subunit docks at two loci on the R subunit, the 
pseudosubstrate region and the CBD-A. Within the CBD, previous studies using 
RIα(91-244) identified the C-terminal end of the A-helix (residues 144-148) as an 
important locus for intersubunit interactions (26).
1.73  Effects of PKA-C and cAMP binding on RIα(91-244)
 Solvent accessibility by amide H/2H exchange Mass Spectrometry studies 
showed that the cAMP-binding pocket (residues 202-221) is more exposed when 
the C-subunit is bound to it compared to the cAMP bound as well as the cAMP 
free forms (26). The region in the A-helix which shows protection from solvent 
upon binding the C  subunit (residues 144-148), becomes more exposed upon 
cAMP binding as compared to the cAMP-free form. 
1.74  Binding Surface on the Catalytic subunit
 RIα docks at three distinct surfaces on the C subunit.
Site1 - The inhibitor sequence in the linker region of RIα docks at the active site 
cleft of the C-subunit. This sequence, Arg94-Arg-Gly-Ala/Ser-Ile98, has a 
phosphorylatable Ser or Thr in case of substrates and Ala or Gly in case of 
pseudosubstrates (PKA-RIα and PKI) 
Site 2 - The hydrophobic region of the PBC containing the Tyr205  interacts with 
a hydrophobic region on the G-helix of the C-subunit around the residue Tyr247. 
Site 3- The residues Trp196 and Arg194 on the activation loop of PKA-C  interact 
with Glu105 in the linker segment and Met 234 in the C-helix of RIα (27).
1.75 The cAMP switch / charge relay 
 The equatorial exocyclic oxygen of the phosphate of cAMP forms a salt 
bridge with the guanidinium side chain of the invariant Arg209 in the PBC of RIα
(91-244). The Arg209 contacts the side chain carboxylate group of Asp170 and 
transmits the signal of cAMP binding. This interaction also neutralizes the charge 
on Arg209. The signal is further relayed by  Arg226 and Glu101 (hypothesized) 
leading to dissociation of PKA-C  (Fig.1-7). This Arg residue is critical to this 
signal relay and replacing it with Lys abolishes high affinity cAMP binding at 
CBD-A (28).
Figure 1-7.  Hypothesized Charge Relay linking Arg209 with PKA-C dissociation
1.8  cAMP analogues
 Cyclic nucleotide analogs present a huge potential for use in biochemical 
and pharmacological studies involving PKA. Several analogs have been 
synthesized and tested, however Rp-cAMPS (Rp-adenosine 3’,5’-cyclic 
monophosphorothioate) and related derivatives are the only known cAMP 
analogues that act as antagonists and competitive inhibitors of cAMP mediated 
PKA activation.
  Rp-cAMPS has a single sulfur substitution of the exocyclic equatorial 
oxygen. The corresponding diastereomer Sp-cAMPS with a single sulfur 
substitution at the exocyclic axial oxygen is a cAMP agonist (Fig. 1-8). The sulfur 
substitution reduces the overall binding affinity  for CBD-A by 400-fold for Rp-
cAMPS and 5-fold for Sp-cAMPS (29). However, previous crystallographic 
studies revealed that the distance between the exocyclic equatorial sulfur of Rp-
cAMPS to the NH1 atom of Arg209 was 2.6Å and between the equatorial oxygen 
of cAMP and the nitrogen atom was 3.1 Å (30). This suggested a stronger focal 
interaction between Rp-cAMPS and CBD-A despite a low overall affinity in 
comparison to cAMP. 
 The strength of this interaction has been attributed to formation of a 
stronger salt bridge-like electrostatic interaction between the surface charge of 
sulfur and the positively  charged guanidinium side chain of Arg209. Resonance 
of electrons between the two exocyclic oxygens allows only weak hydrogen 
bonds to form between cAMP and the Arg209 side chain (30). This stronger 
interaction significantly weakens contacts between Arg209 and Asp170, resulting 
in termination of the signal for PKA-C dissociation, enabling Rp-cAMPS to lock 
the RIα(91-244)-C complex in the holoenzyme conformation rather than cAMP-
bound conformation. However, the Rp-cAMPS analog allows the signal from the 
2’OH- Glu200 interaction to remain undisturbed and hence the analog allows us 
to study the effects of this interaction on the ternary complex. On the other hand, 
Sp-cAMPS with a sulfur substitution in the axial exocyclic oxygen is a cAMP 
agonist, causing the dissociation of the RC holoenzyme and hence acts as a 
close cAMP mimic. 
                                  
Figure 1-8. Diastereomeric Analogs of cAMP; Rp-cAMPS and Sp-cAMPS with a single 
sulfur substitution at the equatorial oxygen for Rp-cAMPS and at the axial position for 
the Sp-cAMPS.
2.Materials and Methods
2.1 Protein expression and purification
2.11 PKA RIα91-244 expression-
 The pRSET vector containing the RIα(91-244) gene insert was 
transformed into BL21DE3 cells and plated onto LB-Ampicillin agar plates. The 
transformants were then cultured overnight. This preinoculum was used to scale-
up  the culture to a 4 l culture volume. Cells were grown to an OD 600 of 0.8-1.0 at 
37°C, with rotation at 220 rpm in an incubator shaker after which the cells were 
induced with 500mM IPTG and allowed to grow overnight (16-18 hr) at 22°C 
while rotating at 180 rpm. The cells were then centrifuged at 6000 rpm for 30 min 






2.12  PKA RIα(91-244) purification-  
 10 gm of the cell pellet was resuspended in lysis buffer  A (20 mM MES, 
100 mM NaCl, 2 mM EDTA, pH6.5), 5ml of the buffer A was used for every gram 
of cell pellet. The cell suspension was then sonicated to lyse the cells at 28% 
amplitude for 8 min at a 1-on,1-off pulse ratio. The cell lysate was then 
centrifuged at 13000 rpm for 30 min at 4°C to pellet the cellular debris. The 
supernatant was carefully separated into a new 50 ml tube. 
 The supernatant was then subjected to ammonium sulfate precipitation at 
40% saturation for 1-2 hr at 4°C while being mixed with a magnetic stirrer. Salt 
was added gradually  to prevent salting out of other proteins. The post-
precipitation solution was then centrifuged at 4000 rpm for 10 min. The 
supernatant was discarded by aspiration or decantation. The pellet was 
resuspended in lysis buffer A. The suspension was incubated with activated and 
equilibrated cAMP-agarose resin overnight (12-16 hr). (method described below)
At the end of the incubation period, the resin was separated from the suspension 
by centrifugation at 3000 rpm for 8 min at 4°C. The flow-through was carefully 
aspirated out and the resin was washed repetitively with the lysis buffer to 
remove nonspecifically bound proteins. Washes were carried out until no protein 
content was detected with Coomassie  protein assay reagent.
 The resin was then incubated with 10 ml elution buffer A (50 mM MES, 
200 mM NaCl, 2 mM EDTA, 40 mM cGMP, pH 5.8) for 2-4 hrs at room 
temperature with constant agitation on a rocker. The elutions were collected by 
centrifugation of the resin at 3000 rpm for 8 min, at 4°C. The eluted protein was 
then concentrated using a Sartorius VIVASPIN 20 (10000 MWCO) filter device. 
The concentrated sample was subsequently loaded onto a GE HiLoadTM 16/60 
SuperdexTM 75 prep  grade gel filtration column. The flow rate and fraction 
volume were set at 0.5ml/min and 0.5ml respectively. The fractions 
corresponding to the resulting peak were collected (Fig.2-1).
Figure 2-1. Gel-Filtration Profile for PKA RIα(91-244) with SDS-PAGE gel of purified 
sample(inlay). The marker label represents protein size in KDa.
2.13 Equilibration of cAMP agarose resin- 
 NHS-activated Sepharose 4 fast flow (GE Healthcare), a pre-activated 
agarose matrix supplied by GE, was coupled with 8-AEA-cAMP through a spacer 
arm. A bed volume of 2 ml of the resin was taken in a 50 ml tube. The resin was 
reactivated by three alternative washes with High pH Buffer (200mM 
ethanolamine, 500 mM NaCl, pH 8.3) and Low pH Buffer (200mM potassium 
acetate, 500mM NaCl, pH 4.0). The activated resin was equilibrated by three-
four washes with the lysis buffer. For every wash 30 ml of each buffer was added 
to the 50 ml tube containing the resin and centrifuged at 3000 rpm for 8 min at 
4°C. Upon centrifugation, each buffer was carefully aspirated out while taking 
care not to disturb the resin bed. 
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 The clone expressing N-terminal hexahistidine tagged PKA-C was 
transformed into BL-21DE3 cells and grown overnight in LB media with 100mM 
Ampicillin at 37°∘C with shaking at 220 rpm. The overnight culture was used as 
preinoculum for a large scale culture preparation (2l). The cells were grown to an 
OD600- 0.8-1.0 and subsequently  induced with 500mM IPTG. The culture was 
grown overnight (16-18 hrs) at 22°C, 180 rpm. The cells were then centrifuged at 
6000 rpm for 30 min at 4°C. The cell pellet was stored at - 20°C. 
2.15 PKA-C purification-  
 1 gm of the pellet was weighed and resuspended in Lysis Buffer (20mM 
Tris, 300mM NaCl, 5mM β-ME, pH 7.5). The cell suspension was then subjected 
to sonication at 28% amplitude with a 1 sec-on, 1 sec-off pulse cycle for 5 min. 
The sonicated cell lysate was centrifuged for 30 min at 13000 rpm, 4°C, to pellet 
down the cellular debris. The supernatant was carefully  aspirated and 
subsequently  incubated with 0.5 ml of equilibrated TALON® Metal Affinity Resin. 
The incubation was carried out for 1-2 hrs at 4°C with constant rotation on a 
gyrating shaker. Subsequently the resin was washed with Lysis Buffer B. The 
protein was eluted out using elution buffer B (20mM Tris, 300mM NaCl, 200mM 
Imidazole, 5mM β-ME, pH 7.5). The eluted protein was then concentrated using 
Amicon-Ultra 15 (10000 MWCO) filter devices by centrifuging at 3000 rpm until 
the volume of the sample reduces to 2ml. The sample was then loaded onto a 
GE HiLoadTM 16 /60 SuperdexTM 75 prep  grade gel filtration column. The flow 
rate for the buffer (lysis buffer B) and the fraction volume settings were the same 
as used in PKA-R purification. Upon completion of the run, the fractions 
corresponding to the resulting peak were collected (Fig. 2-2).
Figure 2-2.  Gel Filtration profile of PKA-C with SDS-PAGE gel of purified sample
(inlay).The first peak is aggregated PKA-C. The marker label represents protein size in 
KDa.
2.2  RIα(91-244):C holoenzyme formation 
 The concentrations of the RIα(91-244) and the PKA-C gel-purified 
samples were quantified using Coomassie protein assay reagent. The two 
proteins were then mixed in a molar ratio of 4: 1 (RIα(91-244):PKA-C) and 
dialyzed against 2l of MOPS holoenzyme buffer (50mM MOPS, 50mM NaCl, 
2mM MgCl2, 0.2mM ATP, 1mM β-ME, pH-7.0) for 16-18 hrs at 4°C. Upon 
completion of the dialysis, the sample was concentrated using Amicon Ultra-15 
(10000 MWCO) filters. The concentrated sample was reloaded into the above 
mentioned gel-filtration column, with the flow rate and fraction volume set at 0.2 
ml/min and 0.5 ml respectively. The resulting profile showed two peaks, the first 
higher molecular weight peak corresponded to the RIα(91-244):C  holoenzyme 
while the second peak corresponded to the excess unbound RIα(91-244). The 
holoenzyme peak fractions were collected and concentrated to 6 mg/ml (Fig.2-3).
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Figure 2-3.  Gel (Sepharose)  Filtration profile of RIα(91-244):C holoenzyme formation, 
with the first peak representing the complex and the second peak representing excess 
RIα(91-244) . Inlaid is the SDS-PAGE gel of the first peak. Comparison of the elution 
profile with standards provided by  the manufacturer showed that RIa(91-244) eluting as 
a monomer (data not shown- http://www.gelifesciences.com/aptrix/upp01077.nsf/
Content/Products?OpenDocument&moduleid=165424). Independent tests by  several 
groups including our own showed that the RIα(91-244):C and RIα(91-244) prepared in 
exactly  the same manner described above generated monomeric forms of the 
holoenzyme complex (Kim et al. (2005), reference) and RIα(91-244) (Badireddy, 2010, 
Manuscript submitted).
2.21  Rp-cAMPS bound RIα(91-244)-C-
 The cAMP analog, Rp-cAMPS was added to a final concentration of 1mM 
to 50 μl of the RC sample.
2.22  Sp-cAMPS bound RIα(91-244):C-
 Sp-cAMPS is a cAMP analog and addition of the same to the RIα
(91-244):C  complex leads to dissociation. Hence an experiment was designed by 
using information about the kinetics of the RIα(91-244):C  complex in the 
presence of Sp-cAMPS. In this experiment, increasing relative concentrations of 
one interacting partner versus the other, from the values of the KD, ensures 
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nearly  all of the other partner to be in the complexed form (Anand, Bishnoi,Taylor 
and Johnson (2009) (Manuscript in preparation)). The program “% Bound” was 
used to calculate the above mentioned concentrations (31). Final concentration 
30 μM PKA-C and 10 μM RIα(91-244) were mixed with 10 μM Sp-cAMPS to 
form the ternary complex.
2.3  Amide Hydrogen/Deuterium Exchange
 Amide hydrogen/deuterium exchange followed by  mass spectrometry  is a 
method used to analyze the structure and dynamics of proteins. Some hydrogen 
atoms in proteins are capable of exchanging with the hydrogen atoms of the 
surrounding solvent molecules. If deuterium oxide is used as a solvent then the 
isotope of hydrogen, deuterium gets incorporated into the protein and as 
deuterium is one mass unit heavier than hydrogen so upon deuteration the 
protein also becomes correspondingly heavy and this change in mass can be 
monitored by high resolution mass spectrometers.
Amongst the three kinds of hydrogens in proteins, hydrogens covalently bound to 
carbon atoms, side chain hydrogens and backbone amide hydrogens, only the 
backbone amide hydrogens exchange at a rate that can be detected. Since 
backbone amide hydrogens are involved in hydrogen bond formation in 
secondary structure elements, their exchange rates are reflective of structural 
stability. Also studying exchange rates of backbone amide hydrogens present at 
the surface of proteins can be used to detect binding of other proteins and 
analyze protein complexes.
This exchange rate is specific and is determined by the protein structure and 
solvent accessibility and is also strongly pH dependent.
 Exchange reactions are carried out at physiological pH(7.0-8.0) since proteins 
are closest to their native conformational state in this range and since the 
exchange rate for backbone amide hydrogens is minimum at pH 2.6 , so by 
rapidly lowering the pH the exchange reaction can be slowed down or quenched. 
Upon quenching the exchange reaction, the protein is digested by a protease in 
order to localize and quantify  the deuterium exchange. Pepsin, an acid protease 
which is active at low temperature is mostly used, it maintains the quench pH 
which ensures minimum back exchange. Other acid stable proteases can also 
be used to achieve different sequence coverage and resolution.
  The exchange experiment was carried out by incubating 2 μl of the protein 
with 18 μl deuterated MOPS buffer for 0,0.5,1,2,5,10 min time points at room 
temperature. The amide exchange was terminated by adding 180 μl of the 
quench buffer (0.05% TFA, chilled). Peptic digestion was carried out by  adding 
100 μl of the quenched sample to 50 μl of activated pepsin slurry. The digestion 
was carried out on ice for 5 min with periodic vortexing every 30 sec. 
The digested sample was then centrifuged at 13900 rpm for 15 sec to pellet the 
pepsin slurry and the supernatant was aspirated out into three 18 μl aliquots and 
immediately flash frozen in liquid nitrogen. The frozen samples were stored at - 
70°C till data collection (32).
2.4  Data collection- 
 The samples were transferred to a liquid Nitrogen can and taken to the 
Mass Spectrometry  facility. Each sample is quickly thawed and 2μl of the sample 
is mixed with 2 μl of matrix (3mg α-Cyano-4-hydroxycinnamic acid (Sigma))
dissolved in 200 μl Acetonitrile, 200 μl Ethanol and 200 μl 0.1% TFA (pH 2.5). 
0.5 μl of this mixture was spotted onto a MALDI-TOF plate. The data was 
collected from the spot using the ABI 4800 MALDI-TOF/TOF Mass Spectrometer 
(33).
2.5  Data Analysis-
 Each sample when injected into the ABI 4800 MALDI-TOF/TOF Mass 
Spectrometer yielded a range of spectra. Spectra were calibrated using Data 
Explorer (Applied Biosystems) with internal peptide masses- 1011.4609 (RIα
(91-244), residues 222-229) and 1793.9704 (C-subunit, residues 247-261), 
pepsin proteolytic fragments.  The centroid of the peptide envelopes were 
measured using Decapp Mass Spec Isotope Analyzer computer program (32). 
The calibrated peptides were then centroided using program “Decapp”. The 
program calculates the centroid of each peak spectrum by averaging the 
intensity of the constitutive peaks. The centroids for the undeuterated sample 
(proteo) were also calculated. The side chain correction value for each peptide 
was determined by adding the number of exchangeable side chain amide 
hydrogens and multiplying that value to a dilution factor of 0.045. This factor was 
calculated considering the various steps of dilution undergone by the sample, i.e. 
ten times dilution upon mixing with deuterated buffer (90% diluted), followed by 
ten times dilution by the quench buffer (9%diluted) and finally two times dilution 
by mixing with Matrix (4.5% dilution). The back-exchange factor was calculated 
to be ~66%, so all centroid values were multiplied by a back exchange factor or 
3.0 to calculate the experimental deuterium exchange levels. The experimental 
number of exchanged deuterons for each peptide was calculated by subtracting 
the undeuterated centroid value and the side-chain correction value from the 
centroid value and dividing it by the back exchange factor. This value indicates 
the average number of deuterons exchanged.
3.   Results
3.1  Measurement of solvent accessibility changes in the holoenzyme of 
PKA upon binding of Rp-cAMPS
 In order to investigate the basis for the antagonist effects of Rp-cAMPS on 
PKA activation, we set out to compare the solvent accessibility  changes between 
the free and Rp-cAMPS-bound states of PKA holoenzyme.  Solvent accessibility 
measurements were made by amide H/2H exchange MALDI-TOF mass 
spectrometry (32). The two samples chosen for a comparative analysis were the 
PKA holoenzyme formed between the C-subunit and a deletion fragment of RIα, 
RIα(91-244) in the absence and presence of Rp-cAMPS. 
 RIα(91-244) is the smallest deletion fragment of PKA RIα that binds the C-
subunit with an almost similar affinity as full-length RIα (20), (22). In addition to 
binding the C-subunit with high affinity, this fragment has additional advantages. 
It is monomeric and contains a single cAMP binding site making it a facile model 
to understand detailed and structure and dynamics of intersubunit interactions in 
PKA by both X-ray crystallography (27) and NMR (34). These reasons were the 
basis for our choice of this deletion fragment complex to study the effects of Rp-
cAMPS binding by Amide H/2H exchange coupled to MALDI-TOF mass 
spectrometry.  Furthermore, this technique is better suited to analyze smaller 
proteins due to better protein sequence coverage as a result of the lower 
likelihood of overlapping pepsin-digest fragments (32). 
 Deuterium incorporation into the rapidly exchanging backbone amides in 
the RIα(91-244):C complex in the free and Rp-cAMPS bound states were carried 
out by incubation of all protein samples in MOPS buffer in D2O at 25°∘C. 
Reactions were quenched by lowering temperature and pH to 2.5 as described in 
materials and methods. Pepsin cleavage under quench conditions allowed 
localization of the observed changes in solvent accessibility to specific pepsin 
proteolytic peptide fragments as described previously (24).  A total of 8 peptides 
from RIα(91-244) and 15 peptides from the C-subunit were analyzed. Tables 1 
and 2 summarize the extent of deuteration of all peptides from RIα(91-244) and 
the C-subunit respectively. For select segments of both subunits where changes 
were observed, plots of the time-course of deuteration are also shown 
(Fig.3-1,3-2,3-3). Average number of deuterons exchanged during a 10-min 
exposure to deuterium oxide were determined from fitting plots of the time 
course of deuteration to a single-exponential equation and reported from 
replicate experimental measurements and standard error of the fits to the 
amplitude term of a single-exponential equation.  This method of data 
presentation has been demonstrated to result in the same conclusion as with 
average numbers of deuterons incorporated after 10-min deuterium exchange 
from three independent experiments (26). To distinguish between specific and 
non-specific effects of the binding of Rp-cAMPS to PKA, we set out to use Sp-
cAMPS as a control in our solvent accessibility  measurements. Due to the much 
lower affinity of the R and C-subunits in the presence of Sp-cAMPS compared to 
the Rp-cAMPS, the concentrations of the R and C-subunits used in the 
experiment were modified for the Sp-cAMPS binding experiments to ensure 
saturation of the complex in the presence of Sp-cAMPS. Two experimental 
conditions were attempted. In order to measure solvent accessibility changes 
within RIα(91-244) in the presence of Sp-cAMPS and C-subunit, an excess of 
the free C-subunit was used and similarly  an excess of RIα(91-244) was used to 
maintain all of the C-subunit in an R-subunit-bound state in the presence of Sp-
cAMPS. The presence of an excess of one subunit relative to the other in each 
of these experiments decreased the overall signal and only a few peptides could 
be analyzed compared to the holoenzyme in the presence of Sp-cAMPS. 
Overall, a majority  of the peptides analyzed showed increased solvent 
accessibility upon binding Rp-cAMPS. Peptides from each of the two subunits 
have been separated and grouped on the basis of their primary sequences.
3.11 Solvent accessibility changes in the RIα (91-244)  :C  complex when 
bound to Rp-cAMPS 
3.111  The α-Xn helix 
 The α-Xn helix represented by two peptides (m/z = 1783, residues 
111-125, m/z= 1619, residues 122-136) showed increased solvent accessibility 
of 17.8% and 14.5% respectively upon binding Rp-cAMPS. Peptide spanning 
residues 111-125 in the sample of PKA with Rp-cAMPS showed nearly maximum 
deuteration within 10-min suggesting this is part of a highly dynamic region 
connecting the pseudosubstrate region with the cAMP:A domain (Fig. 3-1). 
Figure 3-1.  Time-course plot for deuteration of the RIα(91-244) α-Xn helix peptide
(111-125)
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3.112 The loop connecting α:Xn to α:A and 1st turn of α:A helix
 The A-helix peptide m/z = 976.4, residues 136-143, which is one of the 
regions that form part of the extensive C-R intersubunit interface based on the X-
ray crystal structure of the PKA holoenzyme (27) and contains a few residues 
such as His 136 and Glu 143 which mediate salt bridges with residues in the C-
subunit, was deuterated to the same extent in the bound form. 
3.113 The Phosphate-binding cassette (PBC)
 One peptide (m/z = 1931.15, 204-221) spanned a large part of the 
phosphate-binding cassette (PBC), composed of β-strand 6, a short P-helix, a 
loop, and β-strand 7. Consistent with the fact that this is the cAMP-binding site, 
the solvent accessibility was lower in the Rp-cAMPS-bound samples reflective of 
occupancy of this site. (Fig. 3-2). This region is highly shielded from solvent as a 
large proportion of the residues in this peptide do not exchange within 10 min, 
indicating that this region is largely solvent inaccessible (26).
Figure 3-2. Time-course plot for deuteration of the RIα(91-244) peptide covering the 
PBC
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3.114  α:B-helix (residues 222-229) and α:C (residues 230-244)
  A bulk of the peripheral intersubunit interface in the RIα(91-244):C  
complex is contributed by residues from the α:B and adjoining residues from the 
α:C  helix. Interestingly a bulk of this region did not show any differences in 
solvent accessibility upon binding of Rp-cAMPS. Three peptides, m/z = 1011.46, 
residues 222-229, m/z = 1046, residues 230-238 (Fig.3-3) and m/z = 881.51, 
residues 239-244 showed no difference in solvent accessibility while one 
overlapping peptide, m/z=994.50, residues 238-244 showed increased solvent 
accessibility (Fig.3-3) (increased deuteration by 1) upon binding Rp-cAMPS. By 
subtractive analysis, the site of increased exchange can be localized to the 
backbone amide of residue Arg 239 and its environment. This is consistent with 
the predicted role of this residue in mediating contacts with the 2’OH moiety of 
cAMP via  Glu 200 of the PBC on the basis of molecular dynamics simulation 
experiments (33).
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Figure 3-3.  Time-course plot for deuteration of the two  RIα(91-244) C-helix peptides, 
(230-238) and (238-244).
3.115  Catalytic subunit 
 The N-terminal lobe of the C-subunit showed no difference between the 
antagonist bound and free forms for all regions except for the peptide, m/z 
=1530, residues 28-40 which shows greater exchange in the former state. 
Figure 3-4.  Time-course plot for deuteration of the PKA-C peptide (246-267)
The C-terminal lobe on the other hand was found to have increased solvent 
accessibility upon Rp-cAMPS binding to the RIα(91-244):C.
This was shown by peptides m/z = 1708, residues 237-250, m/z = 2552, 
residues 246-267 (Fig. 3-4), m/z = 1347, residues 278-289, m/z = 303-327, 
residues 303-327.
3.12  Solvent  accessibility changes in the RIα(91-244) subunit when bound 
to Rp-cAMPS
 The RIα(91-244) truncated regulatory subunit was then looked at in apo 
form and compared with the Rp-cAMPS analog. The α-Xn helix and B helix 
peptides, m/z=1783, residues 111-125, m/z=1011, residues 222-229 respectively 
showed no difference in solvent accessibility. The C-helix peptide m/z= 881, 
residues 239-244 which lies at the end of this truncated protein shows the same 
solvent exposure upon binding the ligand, whereas the peptide m/z=1046, 
2552(246-267)


















residues 230-238 in the same helix showed an increase in one deuteron upon 
binding. The phosphate binding cassette showed a protection of 3 deuterons 
between the unbound and Rp-cAMPS bound form which is about 18% less 
deuteration (Table 1).
Table 1 -  Maximum H/2H Amide Exchange of the Regulatory Subunit (RIα

















   α:Xn Dex*
111-125 (1783) 13 9.6±0.3 11.3±0.3* 12.4±0.1 12.7± 0.2
122-136 (1619) 14 8.3±0.2 9.5±0.3* ND ND
   A-helix
136-143 (976) 7 3.7±0.2 3.2±0.2 ND ND
   Phosphate -binding cassette
204-221 (1931) 16 4.5±0.1 3.1±0.1* 6.3±0.4 3.5±0.1
   C-helix
222-229 (1011) 7 1.1±0.1 1.0±0.2 1.5±0.2 1.6±0.4
230-238 (1046) 8 3.5±0.1 3.7±0.2 5.4±0.4 6.4±0.9
238-244 (994) 6 2.0±0.1 3.2±0.2* ND ND
239-244 (881) 5 2.3±0.1 2.3±0.1 2.9±0.4 2.9±0.2
* No. of deuterons exchanged over a 10 min time course obtained from kinetic 
plots of deuterons which fits best to a single exponential model. This model 
approximates the rates of fast changing deuterons (mainly solvent accessible 
amides) to a single rate.
ND - not detected. 
 Table 2 - Maximum H/2H Amide Exchange of the Catalytic Subunit 
Complexed to RIα(91-244)
Fragment of No. RIα(91-244):C RIα(91-244):C
C-subunit (m/z) of amides (apo) (+Rp-cAMPS)
Dex*
18-26(1068) 8 5.9±0.1 6.4±0.2
28-40(1530) 11 9.0±0.2 9.8±0.3*
41-54(1584) 13 6.2±0.2 5.8±0.3
44-54(1194) 10 3.6±0.2 4.0±0.2
92-100(1088) 8 2.7±0.1 2.9±0.1
133-145(1628) 11 2.8±0.2 3.2±0.1
163-174(1486) 10 2.0±0.2 1.9±0.1
164-174(1373) 9 1.0±0.2 0.9±0.1
212-221(1167) 9 3.0±0.1 3.7±0.1*
237-250(1708) 11 2.0±0.1 2.7±0.1*
246-267(2552) 20 5.7±0.4 8.0±0.3*
247-261(1793) 13 5.3±0.2 6.3±0.2*
247-264(2083) 16 7.4±0.3 7.8±0.3
247-267(2439) 17 5.5±0.2 6.1±0.2
278-289(1347) 11 2.5±0.1 3.9±0.1*
306-326(2379) 17 9.6±0.2 10.1±0.3
303-326(2676) 20 11.1±0.2 12.3±0.3
303-327(2823) 21 11.5±0.8 13.4±0.4*
305-326(2492) 18 10.6±0.1 11.8±0.3*
* No. of deuterons exchanged over a 10 min time course obtained from kinetic 
plots of deuterons which fits best to a single exponential model. This models 
approximates the rates of  fast changing deuterons(mainly solvent accessible 
amides) to a single rate.
3.2 Solvent accessibility changes in the RIα(91-244):C complex when 
bound to Sp-cAMPS
 The ternary complex of RIα(91-244):C with Sp-cAMPS presented limited 
coverage owing to the design of the experiment and the nature of the analog. 
The A-helix covered by  the peptide m/z= 1594, residues 136-148 showed 
increased exchange of five deuterons upon binding Sp-cAMPS (Fig. 3-5). While 
the C-helix peptide m/z =1046, residues 230-238 showed protection from solvent 
in the ternary complex as compared to the holoenzyme (Fig. 3-5). The C-terminal 
of the C-helix however showed no change upon binding Sp-cAMPS; this region 
was covered by the peptide m/z= 994, residues 238-244.
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Figure 3-5. Time-course plot for deuteration of the A-helix peptide (136-148) and the C-
helix peptide (230-238)
3.3  Solvent accessibility changes in the RIα(FL):C complex when bound to 
Rp-cAMPS
3.31 RIαFL- A domain
 The peptides, m/z = 1783, residues 111-125 and m/z = 1594, residues 
136-148 which belong to the α-Xn helix and the A-helix respectively showed no 
change in solvent accessibility  for the complex. As expected, the phosphate 
binding cassette showed increased protection from solvent upon binding with the 
Rp-analog, as shown in the peptide, m/z = 2115, residues 201-220. The C-helix 
peptides m/z = 1011, residues 222-229, m/z = 933, residues 230-247, m/z = 
1286, residues 239-247 showed no change in deuteration after incorporation of 
the Rp-cAMPS (Table 3).
3.32 RIαFL- B domain  
 The peptides which span the cAMP binding domain B showed no change 
in deuterium incorporation upon binding to the cAMP antagonist with the 
exception of peptides m/z = 1175, residues 355-363 and m/z = 1523, residues 
363-374 showed increased deuterium incorporation (Table 3).
3.4 Solvent  accessibility changes in the RIαFL subunit when bound to 
cAMP and Rp-cAMPS
3.41 RIαFL- A domain
 The full length R subunit free of cAMP was compared with cAMP and Rp-
cAMPS bound forms. The A-helix peptide m/z = 1594, residues 136-148 showed 
no change between the cAMP bound and free forms but showed increased 
solvent accessibility upon binding the Rp-analog. The phosphate binding 
cassette which was covered by  the peptide, m/z = 2115, residues 201-220 more 
protection in the Rp-bound form as compared to the c-AMP bound form. The N-
terminal of the  C-helix covered by the peptides m/z = 1011, residues 222-229 
and m/z = 933, residues 230-247 showed increased solvent accessibility  upon 
binding Rp-cAMPS compared to the cAMP bound protein. This trend was 
reversed in the C-terminal peptide m/z = 1286, residues 239-247 where ligand 
binding led to more protection progressively from cAMP to Rp-cAMPS (Table 3).
3.42 RIαFL- B domain
 The N-terminal peptides m/z = 1561, residues 255-267, m/z = 1330, 
residues 299-309, and m/z = 1338, residues 310-321 showed no significant 
change in protection between the three states. The three peptides m/z = 1953, 
residues 337-353, m/z = 1175, residues 355-363 and m/z = 1523, residues 
363-374 showed reduced solvent accessibility  in the Rp-cAMPS bound state as 
compared to the cAMP bound state. The free state was found to be more 
accessible than the ligand bound states (Table 3).
Table 3- Maximum H/2H Amide Exchange of the RIα FL complexed with the 
Catalytic subunit
Fragment of No. of RIαFL:C RIαFL:C RIαFL RIαFL
RIα-subunit
(m/z) amides (apo) (+Rpanalog) (apo) (+Rpanalog)
cAMP: A domain Dex*
  α:Xn
111-125 (1783) 13 11.2±0.4 11.6±0.3 10.4±0.2 9.7±0.5
A-helix
136-148(1594) 12 3.1±0.4 3.5±0.5 4.3±0.1 5.9±0.5
Phosphate -binding cassette
204-221 (1931) 16 5.8 2.4±0.1 4.5±0.2 ND
C-helix
222-229 (1011) 7 0.9±0.1 1.7±0.3 1.5±0.2 1.9±0.2
230-237 (933) 7 1.2±0.1 1.2±0.1 2.5±0.3 3.4±0.1
239-247 (1286) 8 1.4±0.1 4.9±0.6 4.5±0.3 2.1±0.3
cAMP: B domain
255-267(1561) 12 5.2±0.1 5.1±0.1 5.9±0.0 ND
299-309(1330) 10 4.5±0.0 4.9±0.1 4.0±0.1 4.3±0.4
310-321(1338) 11 3.6±0.0 3.6±0.1 2.3±0.1 2.3±0.3
355-363(1175) 7 4.2±0.1 5.6±0.1 5.2±0.2 3.7±0.2
363-374(1523) 11 10.9±0.2 12.2±0.2 9.2±0.2 6.9±0.2
365-374(1297) 9 8.9±0.1 9.3±0.1 8.0±0.2 6.9±0.1
Phosphate binding cassette
337-353(1953) 13 4.5±0.5 4.4 2.9±0.1 1.2
346-353(1175) 5 1.2±0.3 1.2±0.3 0.9 0.8±0.1
* No. of deuterons exchanged over a 10 min time course obtained from kinetic 
plots of deuterons which fits best to a single exponential model. This models 
approximates the rates of fast changing deuterons (mainly solvent accessible 
amides) to a single rate.
4. Discussion
 cAMP-dependent protein kinase and its mechanism of activation has been 
an object of study for more than two decades. Crystallographic studies 
complemented with Hydrogen/Deuterium exchange, mutagenesis and 
florescence anisotropy are some of the many techniques employed in the course 
of this understanding. Despite the extensive study of the individual subunits as 
well as the holoenzyme, the exact mechanism of activation has remained 
elusive. One of the keys to this mechanism would be in obtaining additional 
information about the intermediate state in the activation of PKA from the inactive 
holoenzyme state to the dissociated catalytic subunit. 
 The regulatory  subunit is believed to exist in two stable conformations in 
vivo : the cAMP-free, PKA-C bound holoenzyme conformation and the cAMP 
saturated, PKA-C free conformation. Upon binding of cAMP the enzyme is 
activated and the R-subunit changes from the former conformation to the latter. 
This change occurs through an intermediate transient complex which consists of 
the holoenzyme bound to cAMP prior to dissociation. This state is relatively 
unstable, as the KD of the complex in the presence of cAMP is 0.2μM compared 
to 0.2nM in the absence of the ligand (20),(34). The relative concentrations of 
cAMP and PKA-C  cause the ternary complex to toggle between each of the 
above mentioned stable conformational states (35). However, if trapped, the 
study of this ternary complex can provide some clues about the intrasubunit 
conformational changes that drive the activation of the enzyme.
 The crystal structure of the PKA holoenzyme reveals detailed insights into 
intersubunit interactions in the PKA holoenzyme (27). The segments of RIα that 
directly interact with the C subunit include residues in the pseudosubstrate 
sequence (Arg94, Arg95, Ala97, Ile98 and Ser99), the linker region (Ala100, 
Val102, Val103, and Glu105), the αXn-αA loop  (Val134, Leu135, and His138), 
αA (Glu143), αB (Glu200, Leu201, Leu204 and Tyr205), and αC (Arg230, 
Leu233, Met234, Thr237, and Leu238)(27). 
 Complementary interface contributing regions in the C-subunit have been 
subdivided into 3 sites (site 1 mainly includes the glycine-rich loop, α:F and 
peptide positioning loop (residues Thr51 and Ser53, Gln84, Glu170, Gly200, 
Pro204 and Glu230)), (site 2 mainly includes the APE linker and a:G helix) 
(Ile210, Leu211, Lys213 Glu248, Val251)), (site 3 primarily includes the activation 
loop residues  Arg 194, Thr195, Trp 196 and Thr 197)). Site 1 of the C-subunit 
thereby interacts with the inhibitor site of RIα, site 2 interacts on the C-subunit 
interacts with the αXn-αA loop, α:A, α:B and α:C of RIα. 
 cAMP which triggers the activation of the enzyme binds to a highly 
conserved V-shaped phosphate binding pocket (11) and its interactions at 
multiple sites send forth signals which have been mapped by several 
crystallographic and mutagenesis studies (23, 24, 11). A primary point of contact 
between cAMP and the PBC in the CBD-A is Arg209. The exocyclic equatorial 
oxygen of the cAMP phosphate interacts with Arg209, which further contacts the 
carboxylate of Asp170,present at the amino terminus of the β3 sheet. This Asp 
residue further relays the signal to Arg226 at the N-terminal of α-C sheet 
facilitating the dissociation of the RC holoenzyme. 
 Rp-cAMPS, a cAMP antagonist, with a sulfur substitution at the equatorial 
oxygen, binds the PBC and uncouples this charge relay because of the reduced 
electronegative polarity and steric hindrance. The Rp-cAMPS analog blocks the 
hypothesized signal relay originating from the equatorial oxygen-Arg209 
interaction. This allows us to  selectively view the effects of the Glu200 mediated 
interaction. While the Sp-cAMPS analog maintains both points of interaction and 
hence acts as a close  cAMP mimic as studied by the RIα(91-244):C.
 Both the full length RC holoenzyme as well as the RIα(91-244):C complex 
were studied in the apo and Rp-cAMPS bound form. The exchange data allowed 
a comparison of the four complexes with each other and with the individual 
subunits. The RIα(91-244):C  complex showed increased exchange in most of 
the regions in PKA-C as well as RIα(91-244) apart from the PBC, which showed 
decreased solvent accessibility corresponding to a difference of 1 deuteron 
exchanged, owing to the occupancy of the site by Rp-cAMPS. 
4.1 Effects of Rp-cAMPS binding can be traced to C-helix peptides in the R-
C interface and when compared with the FL-RC complex shows interesting 
differences in solvent accessibilty.
 The 238-244 region in the α-C helix showed increased deuteration upon 
binding of Rp-cAMPS to the RIα(91-244):C  complex. The RIα(91-244) is 
truncated at the end of the C-helix, the higher solvent exposure in the C-helix of 
RIα(91-244):C as compared to the FL complex is expected. However it is 
interesting to observe that the FL complex shows more solvent exposure in the 
C-helix compared to RIα(91-244):C  when bound to Rp-cAMPS. Five residues of 
the C-helix participates in the R-C interface, - Arg230, Leu233, Met234, Thr237 
and Leu238 (27). This change leads us to believe that the C-terminal end of this 
interaction site is almost completely disrupted.
 A closer look of the C-helix of the RIα91-244:C  complex reveals two 
overlapping peptides, m/z=994, residues 238-244 and m/z=881, residues 
239-244 show an increase in deuteration by one deuteron in the former peptide 
(Fig. 4-1). As pepsin digestion cleaves the N-terminal amine of each peptide , the 
exchange incurred by the peptide is representative of the segment beginning 
from N-terminal+1 residue (36).
 
Figure 4-1. The RIα(91-244) subunit from the RIα(91-244):C complex was drawn using 
Pymol with the pdb file (accession number- 1u7e) (27). The C-helix (green) in RIα
(91-244):C  shows no change in deuteration upon Rp-cAMPS except the environment of 
Arg239 (red). The rest of the protein is labeled in grey.
 Hence by subtractive analysis this change can be localized to the Arg239 
residue. Amide exchange at the backbone amide reports on the environment of 
the residue, hence the change reported by Arg239 could  reflect changes in the 
environment of Leu238 or Lys240. The Leu238 residue interacts with the C-
subunit via van der Waals inteactions. This Leu238 residue is covered by the 
peptide m/z=1046, residues 230-238 which shows a significant reduction in 
exposure upon binding the C-subunit and retains almost the same accessibility 
when the complex binds Rp-cAMPS. This shows that the RC interface is stable 
in this region.
Arg239
4.2  α-Xn helix and A-helix 
 The α-Xn helix interacts with the PKA-C subunit through Val134, Leu135 
and His138 while the α:A helix has a single contact residue, Glu143. The 
corresponding interaction region at the C-subunit has been termed Site-2. The A-
helix peptide m/z=1619, residues 136-143 shows no significant changes in the 
RIα(91-244):C complex when bound to Rp-cAMPS (Fig 4-2) while the α-Xn helix 
peptides m/z= 1619, residues 122-136 and m/z= 1783, residues 111-125 showed 
increased exchange upon binding  Rp-cAMPS (Fig.4-2). 
α-Xn helix A helix
Figure 4-2. The RIα(91-244) subunit from the RIα(91-244):C complex was drawn using 
Pymol with the pdb file (accession number- 1u7e) (27). The α-Xn helix in RIα(91-244):C 
shows increased deuteration (red) while the A-helix shows no change in deuteration 
(green) upon binding Rp-cAMPS. The rest of the protein is labeled in grey.
 
 The residues 111-125 in the α-Xn helix shows differences in solvent 
exposure in different states. The peptide shows no change when the RIα
(91-244) subunit binds to Rp-cAMPS, however it becomes less exposed by 
almost three deuterons in the RIα(91-244):C complex. When Rp-cAMPS binds to 
the complex, this peptide becomes more exposed by nearly two deuterons(Table 
1).This as well as the C-helix peptides convey that although some of the regions 
showing changes in exposure are not a part of the direct interface but the 
changes they undergo influence the overall stability of the RIα(91-244):C 
complex. The data suggests that although the Rp-cAMPS analog locks the 
complex by binding to the phosphate binding cassette, it confers increased 
dynamics to the entire protein. 
 This provides the protein more degrees of freedom and hence more 
possible points of interaction when compared to a more stable structure. This 
entropic favorability coupled with the uncoupling of the charge relay responsible 
for dissociation of C-subunit may lead to the stability  of this ternary complex. It 
has also been previously shown that Rp-cAMPS increases the rate of re-
association of the RC  complex by locking it in a favorable conformation. This 
study validates as well as localizes the changes in this ternary complex with 
respect to the apo form.  
 The changes noticed in the α-Xn helix and the single residue, Arg239 in 
the C-helix brought about by binding of Rp-cAMPS to the RIα(91-244):C are 
contributed solely by  the signal transmitted by the 2’OH-Glu200 interaction. 
These changes could be correlated with increased solvent exposure in most of 
the C-lobe of PKA-C which contributes all of the sites of interaction with the 
regulatory subunit (Fig.4-3). This helped us localize the effects of this signal relay 
in PKA-C dissociation on PKA-C. 
          
Figure 4-3.  The RIα(91-244) subunit from the RIα(91-244):C complex was drawn using 
Pymol with the pdb file (accession number- 1u7e) (27). Increased solvent exposure(red) 
in most of the C-lobe of PKA-C in RIα(91-244):C. The regions labeled green showed no 
change in deuteration and the rest of the protein is labeled in sand color.
4.3  The effects of Sp-cAMPS binding on the RIα91-244:C  reveals a different 
conformation than the Rp-cAMPS bound complex.
 The binding of Sp-cAMPS to the RIα(91-244):C complex leads to 
increased exchange in the A-helix and as this region constitutes a part of the RC 




Figure 4-4.  The A-helix shows increased exposure(red) while a major part of the C-helix 
shows decreased exposure(blue) in Sp-cAMPS bound ternary complex. The rest of the 
protein is labeled grey.
 The C-helix showed protection upon binding Sp-cAMPS while the C-
terminal end of the same helix showed no change (Fig.4-4). This change 
contrasts with the Rp-cAMPS bound complex where the same helix remains 
unchanged. The solvent protection might be due to the combined effects of 
excess PKA-C in the mixture and the binding of a cAMP like molecule. The Sp 
analog allows both the hypothesized signal relays to remain turned on which 
brings about a solvent exposure profile quite different from the RIα(91-244):C 




 The effects of Rp-cAMPS binding when observed in the whole RIα
(91-244):C  complex (Fig.5-1) reveals increased dynamics in the ternary complex, 
substantiating the importance of the 2’OH-Glu200 interaction as playing a part in 
the dissociation of the complex. The primary  site of interaction between PKA-C 
and RIα(91-244) is the active cleft- pseudosubstrate sequence interaction which 
is expected to remain intact as the Arg209 mediated signal that disturbs it is 
absent in the Rp-bound ternary complex. This coupled with increased entropy 
within the complex which also allows more degrees of freedom and consequently 
more possible points of interaction between the two interacting proteins, explains 
why the complex remains locked.
Figure 5-1. The RIα(91-244):C complex was drawn using Pymol with the pdb file 
(accession number- 1u7e) (27) displaying summary of H/2H Exchange Data for the 
Ternary  Complex, RIα91-244:C bound to Rp-cAMPS. The regions labeled in red showed 
increased exchange, the regions labeled in blue showed reduced exchange and the rest 
of the RIα91-244 protein was labeled grey and PKA-C was labeled sand.
PKA-C
PKA- RIα(91-244)
 The critical importance of the Arg209 mediated relay has been 
demonstrated by mutation studies previously  (37) while the Glu200 has been 
known to be important for the binding of cAMP to the PBC. Our results show that 
the role of this interaction (2’OH-Glu200) extends beyond binding and partially 
contributes towards the dissociation of PKA-C from the RIα(91-244):C complex.
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